sorafenib has been researched along with flufenamic acid in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (flufenamic acid) | Trials (flufenamic acid) | Recent Studies (post-2010) (flufenamic acid) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,058 | 69 | 202 |
| Protein | Taxonomy | sorafenib (IC50) | flufenamic acid (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 0.76 | |
| Transthyretin | Homo sapiens (human) | 2.9 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 2.615 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3.112 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 1.4901 | |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 1.3467 | |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 2.64 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, XC; Feng, ZH; Guo, Y; Li, H; Li, ZY; Liao, A; Liu, M; Wang, GX; Wang, JR; Wang, SM; Xu, MQ; Yin, YF; Zhang, S; Zhang, SQ; Zhang, X | 1 |
1 other study(ies) available for sorafenib and flufenamic acid
| Article | Year |
|---|---|
Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid.
Topics: 20-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Dinoprostone; Female; Flufenamic Acid; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Silicon Dioxide; Sorafenib; Xenograft Model Antitumor Assays | 2020 |